Safety and efficacy of preoperative chemotherapy for muscle-invasive bladder cancer in elderly patients
World Journal of Urology · 2023
DOI: 10.1007/s00345-023-04561-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Urology, 2023. Verfasst von Clément Dumont und 13 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Saint-Louis Hospital, AP-HP.Nord Université Paris Cité, 1 Avenue Claude Vellefaux, 75475, Paris Cedex 10, France. clemen…. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE: This study aimed at describing the feasibility and oncological outcomes of standard cisplatin-based neoadjuvant chemotherapy (C-NAC) for muscle-invasive bladder cancer (MIBC) in patients aged ≥ 75 and assess the impact of baseline geriatric parameters. METHODS: This retrospective study included patients with stage cT2-4NanyM0 MIBC aged 75 and older treated with ≥ 1 cycle of C-NAC from 2011 to 2021 at a high-volume academic center. Primary outcome was overall survival (OS). Secondary outcomes were chemotherapy feasibility (administration of ≥ 4 cycles), safety, and pathological downstaging. RESULTS: Fifty-six patients were included. Median age was 79 (range 75-90). C-NAC regimen was ddMVAC in 41 patients and GC in 15. Seventy-three percent of patients received ≥ 4 cycles of C-NAC. Grade ≥ 3 toxicity was observed in 55% of patients. The febrile neutropenia rate was 7%. Thirty patients underwent cystectomy, and 13 underwent chemoradiotherapy. Three-year OS was 63%. Geriatric parameters polypharmacy, undernutrition, and age-adjusted Charlson comorbidity index ≥ 8 predicted worse OS. CONCLUSION: Standard-of-care C-NAC and local treatments are feasible in selected elderly MIBC patients, with efficacy and safety findings similar to that observed in pivotal trials with younger patients. The prognostic impact of geriatric parameters underlines the need for specialized evaluation before treatment initiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Oncology Department, Saint-Louis Hospital, AP-HP.Nord Université Paris Cité, 1 Avenue Claude Vellefaux, 75475, Paris Cedex 10, France. clement.dumont@aphp.fr.
- Université Paris Cité, Paris, France. clement.dumont@aphp.fr.
- Oncogeriatrics Coordination Unit, AP-HP.Nord Université Paris Cité, Paris, France.
- Medical Oncology Department, Saint-Louis Hospital, AP-HP.Nord Université Paris Cité, 1 Avenue Claude Vellefaux, 75475, Paris Cedex 10, France.
- Urology Department, Saint-Louis Hospital, AP-HP.Nord Université Paris Cité, Paris, France.
- Université Paris Cité, Paris, France.
Zitieren
APA
Dumont, C., Aregui, A., Hauchecorne, M., Lefèvre, M., Aussedat, Q., Reignier, P. L., Gauthier, H., Hennequin, C., Fossey-Diaz, V., Xylinas, E., Pachev, A., Desgrandchamps, F., Masson-Lecomte, A., & Culine, S. (2023). Safety and efficacy of preoperative chemotherapy for muscle-invasive bladder cancer in elderly patients. World Journal of Urology. https://doi.org/10.1007/s00345-023-04561-2
Vancouver
Dumont C, Aregui A, Hauchecorne M, Lefèvre M, Aussedat Q, Reignier PL, et al. Safety and efficacy of preoperative chemotherapy for muscle-invasive bladder cancer in elderly patients. World Journal of Urology. 2023. doi:10.1007/s00345-023-04561-2
BibTeX
@article{Dumont2023,
author = {Dumont, Clément and Aregui, Amélie and Hauchecorne, Mathilde and Lefèvre, Madeleine and Aussedat, Quiterie and Reignier, Pierre-Louis and Gauthier, Hélène and Hennequin, Christophe and Fossey-Diaz, Virginie and Xylinas, Evanguelos and Pachev, Atanas and Desgrandchamps, François and Masson-Lecomte, Alexandra and Culine, Stéphane},
title = {Safety and efficacy of preoperative chemotherapy for muscle-invasive bladder cancer in elderly patients},
journal = {World Journal of Urology},
year = {2023},
doi = {10.1007/s00345-023-04561-2}
}
EUVIMED